Литература. 
Липосомы

1. Gregoriadis. G. (1995) TIBECH. 13, 527−537.

2. Yurasov V. V., Kucheryanu V. G.,. Kryzhanovsky G. N,. et al. (1996) Progress in Drug Delivery Systems. Biomedical Research Foundation, Tokyo. Eds. Sadao Hirota, 5, 171−174.

3. Kucheryanu V. G., Yurasov V. V., Kryzhanovsky G. N., et al. (1996) Progress in Drug Delivery Systems. Biomedical Research Foundation, Tokyo, Eds. Sadao Hirota, 5, 179−182.

4. Юрасов В. В., Подгорный Г. Н., Кучеряну В. Г., и др. (1996) Бюллетень эксперим. биол. мед., 122, 614−617.

5. Юрасов В. В., Кучеряну В. Г., Кудрин В. С., и др. (1997) Бюллетень эксперим. биол. мед., 123, 150−153.

6. Maeda H., Matsumura Y. (1989) Crit. Rev. Ther. Drug Carrier Syst., 6, 193−210.

7. Seymour L. V. (1992) Crit. Rev. Ther. Drug Carrier Syst. 6, 135−187.

8. Jain R. K. (1987) Cancer Metastasis Rev. 6, 559−593.

9. Huang S.K., Mayhew E., Lasic D.D., et al. (1992) Cancer Res. 52, 6774−6781.

10. Дранов А. Л., Дудниченко А. С., Бутенко К. А., Краснопольский Ю. М. (1994) Вестн. фармации, № 3−4, С. 88−92.

11. Дранов А. Л., Дудниченко А. С., Мезин И. А., и др. (1996) Бюлл. экспер. биол. мед., № 8, 85−89.

12. Дудниченко А. С., Краснопольский Ю. М. (1996) Бюлл. экспер. биол. 18, 125−129.

13. Дудниченко А. С., Краснопольский Ю. М. (1996) Бюлл. экспер. биол. 18, 392−396.

14. Janoff A.S. (1992) Lab. Invest. 66, 655−658.

15. Gabizon A., Catane R., Uziely B., et al. (1994) Cancer Res. 54, 987 992.

16. Gill P. S., Espina B.M., Muggia F., et al. (1995) J. Clin. Oncol. 13, 996−1003.

17. Forssen E.A., Ross M.E. (1994) J. Lipisomes Res. 4, 481−512.

18. Northfelt D.W., Kaplan L., Russell J., et al. (1995) in Stealth Liposomes (Lasic D.D., Martin F.J., eds). 257−266. CRC Press.

19. Bogner J. R., Goebl F-D. (1995) in Stealth Liposomes (Lasic D.D., Martin F.J., eds). CRC Press. 267−278.

20. Blum G., Cevc G. (1990) Biochim. Biophys. Acta, 1029, 91−97.

21. Klibanov A.L., Maruyama K., Torchilin V.V., Huang L. (1990) FEBS Letters., 268, 235−237.

22. Senior J., Delgado C., Fisher D., et al. (1991) Biochim. Biophys. Acta. 1062, 77−82.

23. Papahadjopouluos D., Allen T.M., Gabizon A., et al. (1991) Proc. Natl. Acad. Sci. USA. 88, 11 460−11 464.

24. Allen T.M., Hansen C. (1991) Biochim. Biophys. Acta. 1068, 133−141.

25. Torchilin V.P., Omelyanenko V.G., Papisov M.I., et al. (1994) Biochim. Biophys. Acta, 1195, 11−20.

26. Torchilin V.P., Shtilman M.I., Trubetskoy V.S., et al. (1994) Biochim Biophys Acta, 1195, 181−184.

27. Gluck R. (1995) In Vaccine Design: The Submit and Adjuvant Approch (Powell M.F., Newman M.J., eds)., Plenum Press. P. 325−345.

28. Le Bang Son, Kaplun A.P., Symon A.V., et al. (1998) J. Liposome Research. 8, 78.

29. Torchilin V.P. (1998) J. Microencapsul, 15, 1−19.

30. Muller R.H., Ruhl D., Runge S., et al. (1997) Pharm. Res. 14 458−462.

31. Yuan F. (1998) Semin. Radiat. Oncol. 8, 164−175.

32. Wiedmann T. S. DeCastro L. Wood R.W. (1997) Pharm. Res. 14, 112−116.

33. Muller R.H., Peters K., Becker R., Kruss B. (1996) Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 22, 574−575.

34. Bohm B.H.L., Grau M.J., Hildebrand G.E., et al. (1998) Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 25, 956−957.

35. Allen T.M. (1997) Drugs, 54, Suppl. 4, P. 8−14.

36. Torchilin V.P. (1996) Mol. Med. Today, 2, 242−249.

37. Torchilin V.P. (1996) J. Mol. Recognit. 9, 335−346.

38. Dass C.R., Walker T.L., Burton M.A., Decruz E.E. (1997) J. Pharm. Pharmacol. 49, 972−975.

39. Aliсo S.F. (1997) Biochem. Pharmacol. 54, 9−13.

40. Жданов Р. И. Куценко Н. Г. Федченко В. И. (1997) Вопр. мед. химии 43, 3−12.

41. Тараховский Ю. С., Иваницкий Р. Г. (1998) Биохимия. 63, 723−736.

42. Yang K., Clifton G.L., Hayes R.L. (1997) J. Neurotrauma. 14, 281−297.

43. Hirnle P. (1997) Hybridoma. 16, 127−132.

44. Rongen H.A., Bult A., van Bennekom W.P. (1997) J. Immunol. Methods. 204, 105−133.

45. Devine D.V., Marjan J.M. (1997) Crit. Rev. Ther. Drug Carrier Syst. 14, 105−131.

46. Imai E., Isaka Y., Akagi Y., Kaneda Y. (1997) Exp. Nephrol. 5, 112−117.

47. Morishita R., Higaki J., Aoki M., et al. (1996) Contrib. Nephrol. 118, 254−264.

48. Schmid M.H., Korting H.C. (1994) Crit. Rev. in Ther. Drug Carrier Syst., 11, 97−118.

49. Sharata H.H., Katz K.H. (1996) Int. J. Dermatol., 35, 761−769.

50. Cevc G., Crit. Rev. (1996) Ther. Drug Carrier Syst., 13, 257−388.

51. Yuan F., Dellian M., Fukumura D.F. et al. // Cancer Res. 1995. V. 55. P. 3752.

52. Lasic D.D., Papahadjopoulos D. // Science. 1995. V. 267. P. 1275.

53. Gabizon A., Schmeeda H., Barenholz Y. // Clin. Pharmacokinet. 2003. V. 42. P. 419.

54. Водовозова Е. Л., Никольский П. Ю., Михалев И. И. и др. // Биоорган. химия. 1996. Т. 22. С. 548.

55. Водовозова Е. Л., Евдокимов Д. В., Молотковский Юл.Г. // Биоорган. химия. 2004. Т. 30. С. 663.

56. Водовозова Е. Л., Кузнецова Н. Р., Кадыков В. А. // Рос. нанотехнологии. 2008. Т. 3. С. 162.

57. Alberts D.S., Muggia F.M., Carmichael J. et al. // Semin. Oncol. 2004. V. 31. P. 53.

58. Kuznetsova N., Kandyba A., Vostrov I. et al. // J. Drug Deliv. Sci. Technol. 2009. V. 19. P. 51.

59. Козлов А. М., Корчагина Е. Ю., Водовозова Е. Л. и др. // Бюлл. экспер. биол. мед. 1997. Т. 123. С. 439.

60. Vodovozova E.L., Moiseeva E.V., Grechko G.K. et al. // Eur. J. Cancer. 2000. V. 36. P. 942.

61. Torchilin VP. (2006)Adv Drug Deliv Rev. 2006 Dec 1;58(14):1532−55.

62. Kimball’s Biology Pages, «Cell Membranes.» .

63. Stryer S. (1981) Biochemistry, 213.

64. Barani, H. & Montazer, M. (2008) A Review on Applications of Liposomes in Textile Processing. Journal of Liposome Research, 18 (3) 249−262.

65. Meure, L.A., Knott, R., Foster, N.R., Dehghani, F. (2009) The Depressurization of an Expanded Solution into Aqueous Media for the Bulk Production of Liposomes. Langmuir, 25, 326−337.

66. L Zhang, FX Gu, JM Chan, AZ Wang, RS Langer and OC Farokhzad (2008). «Nanoparticles in Medicine: Therapeutic Applications and Developments». Clinical Pharmacology and Therapeutics 83 (5): 761−69. doi:10.1038/sj.clp t.6 100 400. PMID 17 957 183. http://www.nature.com/clpt/journal/v83/n5/full/610 0400a.html.

67. Gomez-Hens, A., Fernandez-Romero, J.M. (2006). Analytical methods for the control of liposomal delivery systems. Trends Anal Chem 25:167−178.

68. Mozafari, M.R., Johnson, C., Hatziantoniou, S. & Demetzos, C. (2008) Nanoliposomes and their applications in food nanotechnology. Journal of Liposome Research. 18 (4), 309−327.

69. Mozafari, M.R. & Mortazavi, S.M. (2005) Nanoliposomes: From Fundamentals to Recent Developments. Trafford Publishing Ltd, Oxford, UK.

70. Colas, J.C., Shi, W.L., Rao, V.S.N.M., Omri, A., Mozafari, M.R., Singh, H. (2007) Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting. Micron 38:841−847.

71. Lasic D.D., Papahadjopoulos D. Liposomes revisited: Science. 1995; 267: 1275−6.

72. Harrington K.L., Lewanski C.R., Stewart S.W. Liposomes as vehicles for targeted therapy of cancer/Part.2: Clinical development. Clin Oncol 2000; 12: 16−24.

73. Maruyama К. In vivo targeting by liposomes. Biol Pharm Bull 2000; 23: 791−9.

74. Wright S., Huang L. Advanced Drug Delivery Rev 1989; 3: 343−40.

75. Torchilin V.P., Klibanov A.L., Huang L. et al. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB J 1992; 6: 2716−9.

76. Torchilin V.P., Papisov M.I., Bogdanov A.A. et al. Molecular mechanissm of liposome and immunoliposome steric protection with poly (ethylene glycol) in «Stealth Liposomes». D. Lasic, F. Martin (Eds), P.51−62. CRC Press.

77. Alien T.M., Brandeis E., Hansen C.B. et al. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta 1995; 1237: 99−108.

78. Lopes de Menezes D.E., Pilarski L.M., Belch A.R., Alien T.M. Selective targeting of immunoliposomal doxorobicin against human multiple myeloma in vitro and ex vivo. Biochim Biophys Acta 2000; 1466 (1−2): 205−20.

79. Kirpotin D., Park J.W., Hong K. et al. Sterically stadilized anti-HER2 immunoliposomes: desin and targeting to human breast cancer cells in vitro. Biochemistry 1997; 36: 66−75.

80. Park J.W., Hong K., Kirpotin D.B., Papahandjopoulos C.C., Benz C.C. Adv Pharmacol 1997; 40: 399−435.

81. Papahadjopoulos D., Kilpotin D.B., Park J.W., Hong K., Yi Shao, Shalaby R., Colbern G., Benz C.C. Targeting of drugs to solid tumors using anti-HER2 immunoliposomes. J Liposome Research 1998; 8 (4): 425−42.

82. Dufresne I., Desormeaux A., Bestman-Smith J., Gourde P., Tremblay M.J., Bergeron M.G. Targeting lymph nodes with liposomes bearing anti-HLA-GR Fab' fragments. Biochim Biophys Acta 1999; 1421 (2): 284−94.

83. Bestman-Smith J., Gourde P., Desormeaux A., Tremblay M. J, Bergeron M.G. Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1. Biochim Biophys Acta 2000; 1468 (1−2); 161−74.

84. Lundberg B.B., Griffiths G., Hansen H.J. Specific binding of sterically stabilized anti-B-cell immunoliposomes and cytotoxicity of entrapped doxorubicin. Int J Pharm 2000; 205 (1−2): 101−8.

85. Merrcadal M., Domingo J.C., Petriz J., Garcia J., de Madariaga M.A. Preparation of immunoliposomes bearing poly (ethylene glycol)-coupied monoclonal antibody linked via a clevable disulfide bond for ex vivo applications. Biochim Biophis Acta 2000; 1509: 299−310.

86. Park S., Durst R. A Immunoliposoine sandwich assay for the detection of Escherichia coli 0157: H7. Anal Biochem 2000; 280 (1): 151−8.